by Ruchi Mallya
The cost and time associated with bringing a new blockbuster drug to market is reaching astronomical heights – an average of $1 billion over 12 years…read more

Faced with the challenge of falling success rates in drug development, clinical development teams must find new ways forward. Tessella and Berry Consultants believe that designing smarter clinical trials is part of the solution. We believe that better trial design can help:
• Maximize the impact of your clinical trials on your drug development process.
• Ensure your trial [...]

Yili Pritchett of Abbott was able to show real data from a trial we ran for them between 2007-2009. Read more.

Life Science Leader Magazine – Erie,PA,USA
In 2004, the FDA unveiled a project called the Critical Path Initiative. As then Commissioner of Food and Drugs Andrew C. Von Eschenbach, M.D., later explained to Congress, “This project has the potential to transform the way medical products in the United States are designed, developed, tested, and used.” more

Grant Stephen, CEO, Tessella Inc.
Boston, US | April 2009.  Tessella, the information technology and consulting services company selected by R&D, science and engineering leaders for business-critical assignments, was delighted to present the Knowledge Managements award to Vanderbilt University and to Merck and Abbott Laboratories.
Grant Stephen, CEO of Tessella Inc. presented the awards to Vanderbilt University [...]

Wyeth Research brought home this year’s Bio-IT World Best Practices Award in the Clinical Trial Design category…read more

Adaptive Trial Design Forum, February 26 2009, Windsor, UK
Tom Parke, Head of Clinical Trials Solutions at Tessella is co-hosting along with Scott Berry of Berry Consultants; the first Adaptive Trial Design Symposium, held February 26 2009, Beaumont Estate, Old Windsor, UK.
Sponsored by Cmed, this exciting meeting will be a showcase for Adaptive Trials, with presentations [...]

Webinar: Perspective on the future of drug development, October 16th 2008
The Tessella and Pharmaceutical Business Review free webinar Perspective on the future of drug development. Speakers included Tessella’s Tom Parke and Grant Stephen, Prof Don Berry of Berry Consultants, and Nick Bennett the lead pharma analyst at Datamonitor.

The Tessella and Pharmaceutical Business Review free webinar Perspective on the future of drug development. Speakers included Tessella’s Tom Parke and Grant Stephen, Prof Don Berry of Berry Consultants, and Nick Bennett the lead pharma analyst at Datamonitor.

On July 14th 2008, at the 3rd Trial Design Innovation Conference in Washington DC, Tessella will launch its ‘Adaptive Trials Simulator’: a significant tool designed to help statisticians and managers in the area of designing and supporting Adaptive Clinical Trials.
Adaptive clinical trials increase the efficiency of clinical trials by allowing the trial to adapt to [...]